TAI LCxAlternative Names: TAI-LCx; Turmeric anti-inflammatory - lipophilic compound x
Latest Information Update: 05 Nov 2015
At a glance
- Originator University of Arizona
- Developer Botanisol
- Class Small molecules
- Mechanism of Action Prostaglandin modulators; Tumour necrosis factor alpha modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation